独家消息显示，私募股权巨头TPG正与摩根大通的银行家团队紧密合作，共同评估医疗保健支付软件公司Lyric的潜在出售事宜。据知情人士透露，这笔交易的价值可能高达50亿美元。
消息源称，TPG目前正积极物色潜在买家，并已启动了一系列深入的财务分析和市场调研工作。值得注意的是，这家总部位于医疗科技领域的企业，凭借其创新的支付解决方案，在行业内已建立起显著的市场地位。
与此同时，摩根大通的投行团队将在此次交易中发挥关键作用，预计将为TPG提供全面的战略咨询和交易执行支持。这一举措反映出，在医疗科技投资热度持续升温的大背景下，私募基金正在积极寻求资本退出的最佳时机。
分析人士指出，若该交易最终达成，将成为今年医疗支付软件领域规模最大的并购案之一。不过，消息人士也强调，目前所有讨论仍处于初步阶段，交易时间表和最终结构尚未确定，一切仍存在变数。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.